
¼ÛÁøÈ ±³¼ö
¸¸¼ºÆó¼â¼ºÆóÁúȯ, ¸¸¼º±âµµÁúȯ, °£Áú¼º ÆóÁúȯ, ¹× È£Èí±â Áúȯ
Áø·á½Ã°£ | ¿ù | È | ¼ö | ¸ñ | ±Ý | Åä |
---|---|---|---|---|---|---|
¿ÀÀü | ¿Ü·¡Áø·á | ¿Ü·¡Áø·á | ||||
¿ÀÈÄ | ¿Ü·¡Áø·á |
2013¼¿ï´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø Á¹¾÷ 2021¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇÐ ¹Ú»ç |
2013 ~ 2014¼¿ï´ëÇб³º´¿ø ÀÎÅÏ 2014 ~ 2018¼¿ï´ëÇб³º´¿ø ³»°ú Àü°øÀÇ 2018 ~ 2019¼¿ï´ëÇб³º´¿ø È£Èí±â³»°ú ÀüÀÓÀÇ 2019 ~ 2025Áß¾Óº¸Èƺ´¿ø È£Èí±â³»°ú Àü¹®ÀÇ 2025 ~ ÇѸ²´ëÇб³µ¿Åº¼º½Éº´¿ø ÀÓ»óÁ¶±³¼ö |
´ëÇÑ°áÇÙÈ£Èí±âÇÐȸ ´ëÇÑÆó¾ÏÇÐȸ |
APSR Assembly Education Award (2024) |
1. Beyond the Spirometry: New Diagnostic Modalities in COPD Tuberc Respir Dis (Seoul). 2024 Sep 23 2. Clinical Impacts of Pseudomonas aeruginosa Isolation in Patients with Bronchiectasis: Findings from KMBARC Registry J Clin Med. 2024 Aug 24;13(17):5011. 3. Impact of body mass index on development of nontuberculous mycobacterial pulmonary disease. Eur Respir J. 2021 Feb 4;57(2):2000454. 4. Evolution of Interferon-Gamma Release Assay Results and Submillisievert Chest CT Findings among Close Contacts of Active Pulmonary Tuberculosis Patients. Tuberc Respir Dis (Seoul). 2020 Oct;83(4):283-288. 5. The clinical impact of drug-induced hepatotoxicity on anti-tuberculosis therapy: a case control study. Respir Res. 2019 Dec 16;20(1):283. 6. Evaluation and treatment of latent tuberculosis infection among healthcare workers in Korea: A multicentre cohort analysis. PLoS One. 2019 Sep 19;14(9):e0222810. 7. Evaluation and treatment of latent tuberculosis infection among healthcare workers in Korea: A multicentre cohort analysis. PLoS One. 2019 Sep 19;14(9):e0222810. 8. Prognostic Implication of Adrenocortical Response during the Course of Critical Illness. Acute Crit Care. 2019 Feb;34(1):38-45 9. Effect of intensivist involvement on clinical outcomes in patients with advanced lung cancer admitted to the intensive care unit. PLoS One. 2019 Feb 13;14(2):e0210951. 10. Clinical impacts of the classification by 2017 GOLD guideline comparing previous ones on outcomes of COPD in real-world cohorts. Int J Chron Obstruct Pulmon Dis. 2018 Oct 23;13:3473-3484. 11. Differences in prevalence of asthma-COPD overlap according to different criteria. Medicine (Baltimore). 2018 Sep;97(36):e12049 12. Clinical implications of blood eosinophil count in patients with non-asthma-COPD overlap syndrome COPD. Int J Chron Obstruct Pulmon Dis. 2017 Aug 17;12:2455-2464. |